These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 27762200)

  • 1. Primary and secondary patient data in contrast: the use of observational studies like RABBIT.
    Richter A; Meißner Y; Strangfeld A; Zink A
    Clin Exp Rheumatol; 2016; 34(5 Suppl 101):S79-S86. PubMed ID: 27762200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Safety of biologic therapy - results from the German biologics register RABBIT].
    Strangfeld A; Zink A
    Dtsch Med Wochenschr; 2014 Sep; 139(37):1817-20. PubMed ID: 25180996
    [No Abstract]   [Full Text] [Related]  

  • 3. Health-related quality of life in patients with long-standing rheumatoid arthritis in the era of biologics: data from the German biologics register RABBIT.
    Gerhold K; Richter A; Schneider M; Bergerhausen HJ; Demary W; Liebhaber A; Listing J; Zink A; Strangfeld A
    Rheumatology (Oxford); 2015 Oct; 54(10):1858-66. PubMed ID: 26001633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-world utilization of DMARDs and biologics in rheumatoid arthritis: the RADIUS (Rheumatoid Arthritis Disease-Modifying Anti-Rheumatic Drug Intervention and Utilization Study) study.
    Gibofsky A; Palmer WR; Goldman JA; Lautzenheiser RL; Markenson JA; Weaver A; Schiff MH; Keystone EC; Paulus HE; Harrison MJ; Whitmore JB; Leff JA
    Curr Med Res Opin; 2006 Jan; 22(1):169-83. PubMed ID: 16393443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rheumatoid arthritis registries in Sweden.
    van Vollenhoven RF; Askling J
    Clin Exp Rheumatol; 2005; 23(5 Suppl 39):S195-200. PubMed ID: 16273807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A paradigm shift in studies based on rheumatoid arthritis clinical registries.
    Cho SK; Sung YK
    Korean J Intern Med; 2019 Sep; 34(5):974-981. PubMed ID: 30759964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The British Society for Rheumatology Biologics Register: 6 years on.
    Hyrich KL; Watson KD; Isenberg DA; Symmons DP;
    Rheumatology (Oxford); 2008 Oct; 47(10):1441-3. PubMed ID: 18596052
    [No Abstract]   [Full Text] [Related]  

  • 8. Registry and health insurance claims data in vascular research and quality improvement.
    Behrendt CA; Heidemann F; Rieß HC; Stoberock K; Debus SE
    Vasa; 2017 Jan; 46(1):11-15. PubMed ID: 27871211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Joint damage progression in patients with rheumatoid arthritis in clinical remission: do biologics perform better than synthetic antirheumatic drugs?
    Ciubotariu E; Gabay C; Finckh A;
    J Rheumatol; 2014 Aug; 41(8):1576-82. PubMed ID: 25028383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of concomitant methotrexate in biologic therapy for rheumatoid arthritis.
    Ruderman EM
    Bull Hosp Jt Dis (2013); 2013; 71 Suppl 1():S29-32. PubMed ID: 24219038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An evaluation of the strengths and weaknesses of a register of newly diagnosed rheumatoid arthritis, 1986-2010.
    Young A; Dixey J; Williams P; Prouse P; Cox N; Kiely P; Williams R; Walsh D
    Rheumatology (Oxford); 2011 Jan; 50(1):176-83. PubMed ID: 20929970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EULAR points to consider when establishing, analysing and reporting safety data of biologics registers in rheumatology.
    Dixon WG; Carmona L; Finckh A; Hetland ML; Kvien TK; Landewe R; Listing J; Nicola PJ; Tarp U; Zink A; Askling J
    Ann Rheum Dis; 2010 Sep; 69(9):1596-602. PubMed ID: 20525843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost and effectiveness of biologics for rheumatoid arthritis in a commercially insured population.
    Curtis JR; Chastek B; Becker L; Quach C; Harrison DJ; Yun H; Joseph GJ; Collier DH
    J Manag Care Spec Pharm; 2015 Apr; 21(4):318-29. PubMed ID: 25803765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How well do patient reports reflect adverse drug reactions reported by rheumatologists? Agreement of physician- and patient-reported adverse events in patients with rheumatoid arthritis observed in the German biologics register.
    Gäwert L; Hierse F; Zink A; Strangfeld A
    Rheumatology (Oxford); 2011 Jan; 50(1):152-60. PubMed ID: 20871128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biologics registers in RA: methodological aspects, current role and future applications.
    Nikiphorou E; Buch MH; Hyrich KL
    Nat Rev Rheumatol; 2017 Aug; 13(8):503-510. PubMed ID: 28569267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Making smart investment decisions in clinical research.
    Bansback N; Keystone E; O'Dell J; Phibbs CS; Hannagan K; Brophy M; Anis A
    Trials; 2015 Dec; 16():590. PubMed ID: 26712327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of prior biologic therapy on adalimumab response in patients with rheumatoid arthritis.
    Feuchtenberger M; Kleinert S; Scharbatke EC; Gnann H; Behrens F; Wittig BM; Greger G; Tony HP
    Clin Exp Rheumatol; 2015; 33(3):321-9. PubMed ID: 25897681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ten years of METEOR (an international rheumatoid arthritis registry): development, research opportunities and future perspectives.
    Bergstra SA; Machado PM; van den Berg R; Landewé RB; Huizinga TW
    Clin Exp Rheumatol; 2016; 34(5 Suppl 101):S87-S90. PubMed ID: 27762201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rheumatoid arthritis.
    Lorenzo M
    Foot Ankle Clin; 2007 Sep; 12(3):525-37, vii. PubMed ID: 17765843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Phase IV non-interventional studies in the treatment of rheumatoid arthritis with biologicals in Germany : real-life clinical practice data].
    Ruof J; Iking-Konert C; Simianer S; Burmester GR
    Z Rheumatol; 2014 Feb; 73(1):65-73. PubMed ID: 24264528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.